Baseline characteristics of patients under at-home care system (n=1422)
| Characteristics | Total (n=1422) n (%) | Released from quarantine (n=986) n (%) | Transferred (n=82) n (%) | P value |
| Sex | 0.873 | |||
| Male | 725 (51.0) | 508 (51.5) | 43 (52.4) | |
| Female | 697 (49.0) | 478 (48.5) | 39 (47.6) | |
| Mean age, years (range) | 40 (0–87) | 40 (0–83) | 45 (1–87) | 0.051 |
| 0–9 | 156 (11.0) | 109 (11.1) | 3 (3.7) | |
| 10–19 | 122 (8.6) | 73 (7.4) | 10 (12.2) | |
| 20–29 | 151 (10.6) | 112 (11.4) | 8 (9.8) | |
| 30–39 | 263 (18.5) | 194 (19.7) | 14 (17.1) | |
| 40–49 | 186 (13.1) | 120 (12.2) | 11 (13.4) | |
| 50–59 | 221 (15.5) | 152 (15.4) | 11 (13.4) | |
| ≥60 | 323 (22.7) | 225 (22.9) | 25 (30.5) | |
| Underlying conditions | ||||
| Hypertension | 153 (10.8) | 99 (10.0) | 15 (18.3) | 0.020 |
| Diabetes | 43 (3.0) | 28 (2.8) | 7 (8.5) | 0.005 |
| Thyroid disease | 22 (1.5) | 17 (1.7) | 0 (0) | 0.231 |
| Psychiatric disorder | 12 (0.8) | 10 (1.0) | 1 (1.2) | 0.860 |
| Pregnancy | 6 (0.4) | 4 (0.4) | 2 (2.4) | 0.018 |
| Others* | 53 (3.7) | 26 (2.6) | 5 (6.1) | |
| None | 1177 (82.8) | 820 (83.2) | 60 (73.2) | 0.022 |
| Symptoms | 0.009 | |||
| Asymptomatic | 233 (16.4) | 159 (16.1) | 7 (8.5) | |
| Presymptomatic | 160 (11.3) | 89 (9.0) | 15 (18.3) | |
| Symptomatic | 1029 (72.4) | 738 (74.8) | 60 (73.2) | |
| Medicine prescription | 176 (12.4) | 117 (11.9) | 21 (25.6) | 0.020 |
| Transfer to healthcare facilities | 82 (5.8) | |||
| Cumulative percentage of duration from symptom onset to transfer (%) | ||||
| 3 days | 18.3 | |||
| 5 days | 54.9 | |||
| 7 days | 74.4 | |||
| 10 days | 95.1 | |||
| 14 days | 100 | |||
| Median days from symptoms to diagnosis, days (IQR) | 2 (1–4) | 2 (1–4) | 2 (1–3.75) | 0.307 |
| Median days from diagnosis to management, days (IQR) | 1 (0–1) | 1 (0–2) | 0 (0–1) | <0.001 |
| Median management days†, days (IQR) | 8 (5–10) | 8 (6–10) | 3 (2–4.25) | <0.001 |
*Epilepsy, autoimmune disease, liver disease, asthma, bronchiectasis, angina, cerebrovascular disease, ulcerative colitis.
†Released from quarantine and transferred patients, excluded under management.